Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BQ.1.32SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
DN.1.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
FC.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.7.17SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.27SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.1.71SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
DN.1.1.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.17SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
XAJSYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
Q.6 (Alpha)SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.1.78SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.1.64SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
DP.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.2.3.22SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.7.18SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.1.55SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
EA.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.1.29SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.2.5SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.4.1.5SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
CL.1.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.2.9.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.6.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.1.35SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
Q.2 (Alpha)SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
XAVSYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BE.1.4.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.20SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.2.77SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
CP.1.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
CP.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.2.41SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BE.8SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.7.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.7.13.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
DC.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.7.9SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
CP.1.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
EQ.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
DE.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.1.8SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.3.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.2.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.7.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.1.26SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.19SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.2.51SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
ER.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.4.1.10SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
CS.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used